Table 9.
Group | Hepatocyte death | Inflammatory cell infiltration | Fibrosis | Combined score |
---|---|---|---|---|
Normal |
0.8 ± 0.3 |
0.3 ± 0.2 |
0.3 ± 0.2 |
0.5 ± 0.1 |
Model |
5.6 ± 0.9△△ |
3.9 ± 0.4△△ |
3.3 ± 0.6△△ |
4.8 ± 0.7△△ |
Sylimarin |
3.9 ± 0.2* |
2.8 ± 0.6* |
2.3 ± 0.6 |
3.0 ± 0.9* |
Berberine |
3.5 ± 0.4* |
3.1 ± 0.4 |
2.0 ± 0.5* |
3.0 ± 0.6* |
CRAE |
3.8 ± 0.4* |
3.0 ± 0.3* |
2.1 ± 0.4* |
3.2 ± 0.5* |
Bear Bile |
3.1 ± 0.3** |
2.7 ± 0.7* |
2.4 ± 0.5 |
2.8 ± 0.5** |
TUDCA | 4.3 ± 0.7 | 3.5 ± 0.4 | 2.8 ± 0.2 | 4.1 ± 0.4 |
△p < 0.05 when compared with normal group; △△p < 0.01 when compared with normal group; *p < 0.05 when compared with model group; **p < 0.01 when compared with model group.